67P Inflammation Status and Sarcopenia Synergistically Impact Outcomes in Cancer Patients (pt) Treated with ImmunOtherapy (IO) Within the Framework of a Molecular Pre-screening Program (MP) and a Special Medication (ME) Program
ESMO Open（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要